Business Context and Reporting Period
This Form 8-K, dated November 29, 2019, reports on ACM Research, Inc. (ACMR), a Delaware corporation with global headquarters in Fremont, California. The filing details a material definitive agreement regarding the capital increase of its subsidiary, ACM Research (Shanghai), Inc. (ACM Shanghai), in preparation for a listing on the Shanghai Stock Exchange's STAR Market.
Key Financial Metrics and Transaction Details
- Investment Amount: Second Tranche Investors agreed to acquire shares for an aggregate of RMB 228.2 million (approximately $32.4 million USD).
- Valuation: The transaction implies a pre-investment enterprise valuation of ACM Shanghai of RMB 4.84 billion (approximately $688.9 million USD).
- Purchase Price: RMB 13 per share of registered capital, consistent with the price paid by Initial Tranche Investors.
- Ownership Structure Post-Issuance: ACM Research will own 91.7% of ACM Shanghai; First Tranche Investors will own 3.8%; Second Tranche Investors will own 4.5%.
- Board Composition: The ACM Shanghai board will consist of nine members: seven nominated by ACM Research and two nominated by specific Second Tranche Investors.
Material Changes and Agreements
On November 29, 2019, ACM Research and ACM Shanghai entered into a Second Capital Increase Agreement and a Second Supplemental Agreement with eight PRC-based investment firms (Second Tranche Investors) and the Initial Tranche Investors. This follows an initial financing tranche in June 2019 totaling RMB 187.9 million ($27.3 million). The filing does not provide comparative financial performance metrics (revenue, profit, cash flow) for the period, as the document focuses solely on the capital transaction.
Outlook, Risks, and Contingencies
- Regulatory Approval Deadline: ACM Shanghai must obtain required governmental approvals for the capital increase by December 30, 2019, subject to extension by investor agreement.
- Listing Timeline: ACM Shanghai must submit application documents for the STAR Market listing by December 31, 2022.
- Repurchase Contingency: If the listing application is not submitted by December 31, 2022, Second Tranche Investors have the right to require ACM Shanghai to repurchase their shares at the initial purchase price without interest.
- Proceeds Management: ACM Shanghai has voluntarily committed to holding proceeds in segregated cash accounts or short-term, investment-grade instruments until the listing application is submitted or a repurchase is triggered.
Key Facts for Investor Verification
- Verify the status of governmental approvals for the capital increase, with a target deadline of December 30, 2019.
- Confirm the timeline for submitting the STAR Market listing application to the Shanghai Stock Exchange (deadline: December 31, 2022).
- Monitor the ownership dilution of ACM Research in ACM Shanghai, which will stand at 91.7% post-transaction.
- Review the terms of the repurchase option held by Second Tranche Investors if the listing does not proceed by the 2022 deadline.